TMEM106C: A Potential Drug Target and Biomarker (G79022)

Target Name: TMEM106C

NCBI ID: G79022

TMEM106C

TMEM106C: A Potential Drug Target and Biomarker

TMEM106C, also known as T106C human, is a protein that is expressed in various tissues of the human body. It is a member of the transmembrane protein family, which includes proteins that span the membrane of the cell and extend into the cytoplasm or the space between cells. TMEM106C is characterized by its unique potential drug target potential and its ability to interact with various signaling pathways.

TMEM106C is a 21-kDa protein that is expressed in the brain, heart, and pancreas. It is involved in the regulation of various cellular processes, including cell signaling, migration, and adhesion. TMEM106C is a protein that is often targeted by drugs that aim to modulate its function, such as those that target tyrosine kinase signaling pathways.

One of the key features of TMEM106C is its ability to interact with various signaling pathways. TMEM106C has been shown to play a role in the regulation of tyrosine kinase signaling pathways, which are involved in the regulation of cellular processes such as cell growth, differentiation, and survival. TMEM106C has been shown to interact with several tyrosine kinase proteins, including PDGF/TKF1, TGFR2, and Src.

In addition to its role in tyrosine kinase signaling pathways, TMEM106C is also involved in the regulation of several other signaling pathways. For example, TMEM106C has been shown to be involved in the regulation of the Wnt signaling pathway, which is involved in the regulation of cell growth and differentiation. TMEM106C has also been shown to play a role in the regulation of the Notch signaling pathway, which is involved in the regulation of cell survival and proliferation.

The potential drug target potential of TMEM106C is due to its involvement in several key signaling pathways. Its ability to interact with tyrosine kinase proteins and other signaling pathways makes it an attractive target for the development of new pharmaceuticals. Additionally, TMEM106C's localization in various tissues and its expression in a wide range of cellular processes make it a versatile target for drug development.

In conclusion, TMEM106C is a protein that has unique potential as a drug target or biomarker. Its ability to interact with various signaling pathways and its localization in various tissues make it an attractive target for the development of new pharmaceuticals. Further research is needed to fully understand TMEM106C's role in cellular processes and its potential as a drug target.

Protein Name: Transmembrane Protein 106C

The "TMEM106C Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about TMEM106C comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets